Weekly pill could slash migraine days, new trial hopes
NCT ID NCT07072910
Summary
This study is testing if a medication called cabergoline, taken just once a week, can help prevent migraine attacks in adults. Researchers will compare two different doses against a placebo (inactive pill) in 150 people who get 4 to 14 migraine days per month. The main goal is to see if the weekly treatment safely reduces the number of migraine days people experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus N, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.